22
Views
35
CrossRef citations to date
0
Altmetric
Original Article

X-ray Inactivation of Human Cells in Tissue Culture under Aerobic and Extremely Hypoxic Conditions in the Presence and Absence of TMPN

, &
Pages 285-296 | Received 28 Dec 1972, Accepted 19 Feb 1973, Published online: 03 Jul 2009
 

Summary

A technique is described which permits irradiation of suspensions of human cells in tissue culture either aerobically (equilibrated with air) or under extremely hypoxic conditions (flushed with a mixture of 97 per cent N2 and 3 per cent CO2, the oxygen content of which was less than 15 p.p.m.).

An established cell-line, NHIK 3025, originally derived from an early stage of human cancer of the cervix, was used. The D0 value of these cells under aerobic conditions was 130 rads and the extrapolation number about 3. Under extremely hypoxic conditions, the dose-effect curve was exponential with a D0 value of 600 rads. The o.e.r. derived from the ratio of the D0 values was therefore 4·6.

2,2,6,6tetramethyl-4-piperidinol-N-oxyl (TMPN) at a concentration of 10−2 M exerted a pronounced sensitizing effect under extremely hypoxic conditions (TMPN e.r. = 2·5), and yielded dose-effect curves with an extrapolation number of 3. The high radio-resistance of the cell under extremely hypoxic conditions in the absence of TMPN may be relevant to the evaluation of the radio-curability of tumours such as squamous cell carcinoma of the cervix uteri.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.